VELTUZUMAB

UNII: BPD4DGQ314
Preferred Substance Name: VELTUZUMAB

728917-18-8
HA20
IMMU-106
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HA20 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HA20 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HA20 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HA20 .KAPPA.-CHAIN, DIMER
VELTUZUMAB [INN]
VELTUZUMAB [MART.]
VELTUZUMAB [USAN]
VELTUZUMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

VELTUZUMAB

Synonyms and Mappings

Resources

Note